Product Information
IBUPROFEN 200 MG TABLET is a generic product labeled by Cardinal Health, priced at $0.0329 per EA under NDC 70000017508. Its NADAC has been published 231 times since Mar 23, 2022.
FDA first approved this application on Dec 8, 1987.
Strength
200 mg/1
Manufacturer
Cardinal HealthNDC
70000017508
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA072096FDA Approved
12/8/1987
On Market Since
11/30/2016
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN 200 MG TABLET has been published 231 times since Mar 23, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0329 per EA |
|---|---|
| All-time high | $0.0370 (Nov 12, 2025) |
| All-time low | $0.0300 (Apr 17, 2024) |
| 52-week high | $0.0370 |
| 52-week low | $0.0320 |
| Median price | $0.0337 |
| Average price | $0.0337 |
| Largest weekly change | -13.7% (Apr 17, 2024) |
| Weeks tracked | 231 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN 200 MG TABLET, manufactured by Cardinal Health, is $0.0329 per EA (NDC 70000017508), effective Aug 19, 2026.
How has the price of IBUPROFEN 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for IBUPROFEN 200 MG TABLET has held within roughly two percent of its current level. It has been tracked across 231 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for IBUPROFEN 200 MG TABLET?
Since Mar 23, 2022, the NADAC for IBUPROFEN 200 MG TABLET has ranged from a low of $0.0300 (Apr 17, 2024) to a high of $0.0370 (Nov 12, 2025), with a median of $0.0337 per EA.
Are there cheaper alternatives to IBUPROFEN 200 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 200 MG TABLET, is $0.0269 per EA — about 18% below IBUPROFEN 200 MG TABLET.
Who manufactures IBUPROFEN 200 MG TABLET?
IBUPROFEN 200 MG TABLET (NDC 70000017508) is labeled by Cardinal Health, and CMS classifies it as a generic product.